REGENXBIO Inc.
$644.27M- Market cap
- $590.16M
- Debt
- +$284.18M
- Cash
- −$230.07M
Capital structure 67% equity / 33% debt · EV / Revenue 3.78x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
RGNX · current priceP/S 3.46x
$8.94Latest market snapshot
Implied fair value · at NFLX's multiple
$18.62108.3% above market
2.58 RGNX revenue / share×7.21x NFLX P/S=$18.62
Market $8.94Implied $18.62
NFLX · current priceP/S 7.21x
$78.25Latest market snapshot
Implied fair value · at RGNX's multiple
$36.8253.0% below market
10.63 NFLX revenue / share×3.46x RGNX P/S=$36.82
Market $78.25Implied $36.82